Delivery Order SPE2DB20D3101-SPE2DB26FQTF2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Vivitrol 380 mg vial-diluents, with a contract ceiling value of $9,379.02 and an ultimate completion date of October 24, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $6,330.42. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $3,003.48 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of October 23, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $7,385.49. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract calls for delivery to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $5,005.80. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $45,056.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vivitrol 380 mg vial-diluents. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and was awarded competitively without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB26FQTF2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $3,003.48. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. Vivitrol (naltrexone extended-release) is a medication used in substance use disorder treatment programs, representing the type of specialized pharmaceutical commodity that AmerisourceBergen supplies across the Defense Health Agency's medical supply chain. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive federal contract authority to provide brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems globally. This particular delivery order exemplifies the company's role as a critical vendor fulfilling routine pharmaceutical procurement needs for federal medical programs through the DLA's comprehensive pharmaceutical prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/5/25 |